CCNB2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.5387000279764E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.69400000000053E-05 |
Normal-vs-Stage2 |
6.123600E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
9.422400E-03 |
Stage1-vs-Stage2 |
6.068000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.031000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.899800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.09280000498902E-08 |
Normal-vs-AfricanAmerican |
3.752800E-01 |
Normal-vs-Asian |
1.255160E-01 |
Caucasian-vs-AfricanAmerican |
3.117800E-01 |
Caucasian-vs-Asian |
9.774800E-01 |
AfricanAmerican-vs-Asian |
3.641600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.28180000000555E-05 |
Normal-vs-Female |
5.50729999999611E-05 |
Male-vs-Female |
8.186800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.675010E-03 |
Normal-vs-Extreme_Weight |
1.37889999995977E-06 |
Normal-vs-Obese |
6.196600E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.742600E-01 |
Normal_Weight-vs-Obese |
1.922840E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.848400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.396200E-01 |
Normal-vs-Age(41-60Yrs) |
5.81389999999571E-05 |
Normal-vs-Age(61-80Yrs) |
1.225250E-04 |
Normal-vs-Age(81-100Yrs) |
1.382840E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.068600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.889800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.968000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.977200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.273600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.822200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.723700E-02 |
Normal-vs-Grade 3 |
4.299400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.281590E-01 |
Grade 2-vs-Grade 4 |
8.723700E-02 |
Grade 3-vs-Grade 4 |
4.299400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.09670000003614E-06 |
Normal-vs-N1 |
2.882100E-02 |
N0-vs-N1 |
3.843000E-01 |
|
|